Results 61 to 70 of about 459,727 (225)

Trained Immunity in Childhood Vaccination

Acta Paediatrica, Volume 115, Issue 11, Page 2402-2413, November 2026.
Trained immunity as an emerging concept in paediatric vaccinology. Trained immunity links vaccine stimuli through epigenetic and metabolic reprogramming to enhanced innate immune cell function, thereby strengthening protection against diverse pathogens while promoting adaptive immune responses through more efficient antigen presentation and co ...
ChenRongRong Cai, Lubnaa Hossenbaccus, Eva Kaufmann   +2 more
wiley   +1 more source

A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine

International Journal of Analytical Chemistry, 2016
Molecular size distribution of meningococcal polysaccharide vaccine is a readily identifiable parameter that directly correlates with the immunogenicity.
Imran Khan, K. M. Taufiqur Rahman, S. M. Saad Us Siraj, Mahbubul Karim, Abdul Muktadir, Arpan Maheshwari, Md Azizul Kabir, Zebun Nahar, Mohammad Mainul Ahasan   +8 more
doaj   +1 more source

Vaccine Coverage and Vaccination Delays in Children With Chronic Illness: A French Multicentre Point‐Prevalence Survey

Acta Paediatrica, EarlyView.
F. Dubos, C. Santy, J. Toubiana, M. Caseris, J. Gaschignard, A. Morand, P. Minodier, Z. Maakaroun‐Vermesse, E. Launay, M. Lorrot, C. Brehin, I. Hau, E. Jeziorski, A. Tran, A. Agnani, A. Flammang, M. Meurin, M. Lagrée, D. Diallo   +18 more
wiley   +1 more source

Sequential and Concurrent C5 and Neonatal Fc Receptor Inhibition in Prolonged Myasthenic Crisis due to Advanced Invasive Thymoma‐Associated Myasthenia Gravis: A Case Report and Literature Review

Clinical and Experimental Neuroimmunology, Volume 17, Issue 4, November 2026.
ABSTRACT Thymoma‐associated myasthenia gravis (TAMG) is frequently refractory, particularly when complicated by myasthenic crisis in advanced invasive disease. Complement C5 inhibitors and neonatal Fc receptor (FcRn) inhibitors have expanded the treatment of acetylcholine receptor (AChR) antibody‐positive generalized myasthenia gravis; however, their ...
Yuta Kizuka, Yuriko Nakamura, Kensuke Okada, Yu Okubo, Kaoru Kaseda, Hirofumi Toyama, Keisuke Asakura, Atsuya Takeda, Jin Nakahara, Kei Ishizuchi   +9 more
wiley   +1 more source

Recent advances in the development of a vaccine to target meningococcal serogroup X

Expert Review of Vaccines
Introduction Serogroup X has emerged as an important cause of invasive meningococcal disease across Sub-Saharan Africa. Recent advances in serogroup X vaccines were reviewed.Areas covered Early vaccine development efforts focused on outer membrane ...
Kelly Townsend-Payne, Jennifer Louth, Ray Borrow, Stephen A. Clark   +3 more
doaj   +1 more source

Changes in Post‐Transplant Vaccine Coverage After Implementing Structured Vaccine Reviews in Pediatric Solid Organ Transplant Recipients in British Columbia, Canada: A Canadian Immunization Research Network Study

Pediatric Transplantation, Volume 30, Issue 11, November 2026.
Structured annual infectious diseases specialist‐led vaccine reviews, including individualized recommendations, standardized checklists, and facilitated vaccine access, integrated into routine post‐transplant care, significantly improved vaccine coverage in pediatric solid organ transplant recipients.
Florence Anne Barbey, Manish Sadarangani, Catherine Burton, Simon Urschel, Shannon E. MacDonald, Athena McConnell, Estelle Morin, Kevin Meesters, Tom Blydt‐Hansen, Elaine Yong, Hana Mitchell, on behalf of the Special Immunization Clinic Network Investigators   +11 more
wiley   +1 more source

Adesão às novas vacinas conjugadas. Vacina anti-meningocócica e anti-pneumocócica.

Acta Médica Portuguesa, 2004
The new conjugate vaccines against group C meningococcal infection and pneumococcal infection were introduced in Portugal in 2001. In 2001/2002, the media published several alarming news on meningococcal disease and there was an increased demand of those
Laurinda De Queirós, Luis Castro, Maria Carmo Ferreira, Guilherme Gonçalves   +3 more
doaj   +1 more source

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

Advanced NanoBiomed Research, Volume 6, Issue 10, October 2026.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi, Md Mijanur Rahman, Asma Talukder, Urooj Yousaf Virk, Jennifer C. Wilson, Nigel McMillan, Ming Q. Wei   +6 more
wiley   +1 more source

Healthcare professionals’ perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States

Expert Review of Vaccines
Background Invasive meningococcal disease (IMD) is a vaccine-preventable, serious disease. In 2023–2024, the United States (US) Advisory Committee on Immunization Practices (ACIP) proposed revisions to the adolescent meningococcal vaccine schedule.
Oscar Herrera-Restrepo, Laurie Batchelder, Thatiana Pinto, Mickael Henry-Szatkowski, Dian Zhang, Adam Moore, Jennifer Bushen, Telisa Stewart, Jana Shaw   +8 more
doaj   +1 more source

Case Report: Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B‐Cell Depletion Therapy to Ravulizumab

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT This case report illustrates the real‐world efficacy of complement component 5 inhibitors in a patient with neuromyelitis optica spectrum disorder who switched from rituximab because of B‐cell repopulation occurring early in the course of treatment.
Aram Zabeti
wiley   +1 more source